Vera Therapeutics Inc (VERA)

Vera Therapeutics Inc (VERA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.2B; returns 1 day -3.6%, 1 week +0.4%, 1 year -0.7%.

Vera Therapeutics, Inc. is a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious immunological diseases. As of early 2026, the company is pre-revenue, with its valuation and operational focus entirely centered on its lead product candidate, atacicept.

Groups VERA belongs to

• Healthcare
• Biotechnology
• Nephrology
• Clinical Stage
• Clinical Stage Biotech
• Autoimmune Diseases
• Biopharmaceutical
• Rare Diseases
• Unmet Medical Needs
• Immunotherapy

VERA financial model: income statement, cash flow and balance sheet